About Exquiron
Exquiron is a Healthcare company based in Reinach (Switzerland) founded in 2012, and was acquired by Aptuit in April 2016. Early-stage drug discovery services are provided as a CRO. Its focus areas include Biopharma Outsourcing, CRO, Preclinical Studies and Diversified.
Company details
Exquiron was founded in 2012 in Reinach, Switzerland, as a contract research organization focused on the pharmaceutical sector. Services encompass assay development, high-throughput screening, screening libraries, SAR expansion, hit profiling, and in silico drug discovery for early-stage projects. The company was acquired by Aptuit LLC in April 2016, integrating its operations into broader clinical research capabilities.
- Headquarters Reinach, Switzerland
- Stage Acquired
- SectorsHealthcare
- Website exquiron.com
- Social LinkedIn
- Acquired by Aptuit (Apr 2016)
Investors in Exquiron
Exquiron has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Aptuit.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Contract research and development services for small molecules are offered. | 2004 | aptuit.com | Greenwich, United States |
Investor details for Exquiron
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Exquiron
2 dated milestones of Exquiron across 4 years, from founding to its latest funding, stage changes and deals.
- Founded Exquiron is founded.
- Exit Acquired by Aptuit.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Exquiron
Exquiron was founded in 2012.
Exquiron is headquartered in Reinach, Switzerland. It is registered at Reinach, Basel-landschaft, Switzerland.
Exquiron was founded in 2012 in Reinach, Switzerland, as a contract research organization focused on the pharmaceutical sector. Services encompass assay development, high-throughput screening, screening libraries, SAR expansion, hit profiling, and in silico drug discovery for early-stage projects. The company was acquired by Aptuit LLC in April 2016, integrating its operations into broader clinical research capabilities.
Exquiron has 1 investor. Key investors include Aptuit.
Yes. Exquiron was acquired by Aptuit in April 2016.